Skip to main content
Jolan Walter, MD, Allergy & Immunology, Saint Petersburg, FL, Johns Hopkins All Children's Hospital

JolanEWalterMDPhD

Allergy & Immunology Saint Petersburg, FL

Pediatric Asthma & Allergic Conditions

Robert A Good Chair and Division Chief in Pediatric Allergy Immunology University of South Florida at Johns Hopkins All Children Hospital

Dr. Walter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Walter's full profile

Already have an account?

Education & Training

  • Children's Hospital
    Children's HospitalFellowship, Allergy and Immunology, 2006 - 2009
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolResidency, Pediatrics, 2003 - 2006
  • University of Pécs Medical School
    University of Pécs Medical SchoolClass of 1996

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2016 - 2026
  • MA State Medical License
    MA State Medical License 2007 - 2016
  • American Board of Allergy and Immunology Allergy & Immunology

Publications & Presentations

PubMed

Journal Articles

  • Vasculitis as a Major Morbidity Factor in Patients with Partial RAG Deficiency  
    Jocelyn R Farmer, Meredith A Dilley, Kevin Byram, Leonard H Calabrese, Jolan E Walter, Frontiers in Immunology

Abstracts/Posters

  • Characterizing Autoimmune Hemolytic Anemia in RAG Deficiency
    Jolan Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Identifying Primary Immune Deficiencies in Patients with Autoimmune Cytopenias
    Jolan Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • The Growing Pandemic of Secondary Immunodeficiency
    The Growing Pandemic of Secondary ImmunodeficiencyNovember 15th, 2021
  • ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021
    ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021October 4th, 2021
  • Physicians and Researchers Examine How COVID-19 May Impact Children with Immune Deficiency
    Physicians and Researchers Examine How COVID-19 May Impact Children with Immune DeficiencyOctober 1st, 2021
  • Join now to see all

Hospital Affiliations